The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Just noticed a CLN issues for £2mill at 8% convertible into shares for 2022. Basically a 33% share dilution? reference below, seems to be buried in the annual report and i am still hunting...
https://www.proactiveinvestors.co.uk/companies/news/986017/mode-global-holdings-expands-in-anticipation-of-further-growth-in-2022-986017.html
Depends on the trading to date if they raise cash. They defo need cash but it is how they get it and how much. Interesting to see what the year end cash position is. They sold the BTC to help with cash. I think they have dialed down their marketing spend so far this year.
It is gonna be massive.
Management are still not in a rush to publish the cash position for the 2020 year end. Shareholders are pretty well in the dark regarding the business stats for over a year now. Alot of bitterness towards stakeholders by JR is not helpful. Communication by the management team today is still shockingly poor despite everything that has happened. While form a regulatory point of view the annual accounts for 2020 are not late; they are late in spirit and that can only be read into negatively.